January 10, 2017
Omada Health has announced five new senior hires, most notably a new chief medical officer, Dr. Paul Chew, who previously served as senior VP and global chief medical officer at Sanofi. The company also announced the hire of Tom Schoenherr as chief commercial officer, a position he previously held at Counsyl.
“For the last five years, we’ve worked to establish Omada Health as a leader in digital...
December 12, 2016
Melbourne, Australia-based smart inhaler company Adherium has been selected to supply the technology for a multi-country research program in Europe that will seek to establish whether home monitoring and mobile health tools can be used to manage asthma.
Adherium’s Smartinhaler technology, which uses sensors to track when medication is taken and then sends the data via Bluetooth to mobile devices...
November 17, 2016
Correction: A previous version of this article misstated the adherence figure.
Adherium’s Smartinhaler has been shown to increase medication adherence by 43 percent and reduce hospitalization by a factor of five, according to a new study conducted at Sheffield Children’s Hospital in the UK and published in the journal Thorax. The randomized control trial included 77 children with asthma.
September 6, 2016
In a surprising move, Ramzi Haidamus stepped down from his post as president of Nokia Technologies, the Silicon Valley division of Finland-based Nokia Group. Nokia Technologies does not yet have someone to replace Haidamus, and the company says he will stick around until the end of September. In the meantime, Brad Rodrigues, who is currently head of strategy and business at the company, will...
August 16, 2016
Pharmaceutical company AstraZeneca is beginning a clinical trial in collaboration with Quintiles looking at the impact of mobile medication reminders for people with chronic obstructive pulmonary disease (COPD).
The proposed yearlong trial – which is still not yet recruiting participants – will be an intervention study involving an estimated 380 people with COPD divided into two groups. Both...
July 29, 2016
During the month of July, MobiHealthNews reported on 16 digital health companies that raised venture funding. The deals total $149.3 million, which is lower on average when compared to other months this year so far but that's expected for the slower news cycle in the summer.
In the first half of 2016, MobiHealthNews tracked funding for digital health companies that totaled $1.27 billion, as we...
July 20, 2016
Adherium, a Melbourne, Australia-based connected inhaler company, has raised $5.9 million ($8 million Australian) through a private placement of shares with Fidelity. Adherium is publicly traded in Australia. Under the deal, Fidelity will purchase 16 million shares at $0.50 Australian per share, bringing the global asset manager's share in the company to 10 percent.
“Fidelity International are...
April 11, 2016
Anthem's CareMore Health System announced that its president, Leeba Lessin, will retire this week after working at CareMore since 2006. CareMore Chief Medical Officer and Chief Operating Officer Sachin Jain will take over as the new CEO.
“With Dr. Jain in place, I know we have leadership and energy to lead us into the next era,” Lessin said in a statement. “Given CareMore’s focus on clinical...
March 30, 2016
PatientsLikeMe has hired Monique Levy as the company’s SVP, Head of customer strategy and value delivery, which is a new role. Levy will work with PatientsLikeMe’s life science partners to help them meet patients’ needs. Levy is on the Google Health Advisory Board, and prior to joining PatientsLikeMe, she was VP of Research for the Digital Innovation team at Decision Resources Group. Before that...
February 26, 2016
The Medical Research Institute of New Zealand (MRINZ) has announced that it plans to launch an multi-country clinical study, called Novel START, using New Zealand-based Adherium’s connected inhalers. In addition to New Zealand, other study sites will be in Australia, the United Kingdom, and Italy.
Adherium's Smartinhaler sends data on when medication was taken to mobile devices and desktop...